These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


280 related items for PubMed ID: 6588526

  • 21. Role of prostaglandins in gastroprotection.
    Peskar BM, Maricic N.
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):23S-29S. PubMed ID: 9753222
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Role of prostaglandin E2 on gastric ulcers induced by non-steroidal anti-inflammatory compounds (NOSAC).
    Kobayashi K, Arakawa T, Nakamura H, Chono S, Yamada H, Kamata T, Ono T.
    Gastroenterol Jpn; 1981 Dec; 16(6):600-3. PubMed ID: 6949847
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Synthesis of prostaglandin E2, thromboxane B2 and prostaglandin catabolism in gastritis and gastric ulcer.
    Hawkey CJ.
    Gut; 1986 Dec; 27(12):1484-92. PubMed ID: 3468053
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prevention of non-steroidal anti-inflammatory agents induced acute gastric mucosal lesions by carbonic anhydrase inhibitors. An endoscopic study.
    Puscas I, Hajdu A, Buzás G, Bernáth Z.
    Acta Physiol Hung; 1989 Dec; 73(2-3):279-83. PubMed ID: 2596317
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice.
    Takeuchi K, Araki H, Umeda M, Komoike Y, Suzuki K.
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1160-5. PubMed ID: 11356942
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Decreased gastric prostaglandin E2 synthesis in patients with gastric ulcers and in smokers.
    Baumeister B, Schmidt C, Schiermeyer-Dunkhase B, Vetter H, Kipnowski J.
    Hepatogastroenterology; 1995 Jun; 42(6):851-5. PubMed ID: 8847034
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prostaglandins in pathophysiology of peptic ulcer disease.
    Konturek SJ.
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):105S-108S. PubMed ID: 3863751
    [Abstract] [Full Text] [Related]

  • 36. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer].
    Fich A, Stalnikowicz R, Goldin E, Eliakim R, Wengrower D, Ligumsky M, Karmeli F, Rachmilewitz D.
    Harefuah; 1986 Nov 16; 111(10):292-5. PubMed ID: 3817615
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparison of prostaglandin and cimetidine in protection of isolated gastric glands against indomethacin injury.
    Brzozowski T, Tarnawski A, Hollander D, Sekhon S, Krause WJ, Gergely H.
    J Physiol Pharmacol; 2005 Sep 16; 56 Suppl 5():75-88. PubMed ID: 16247190
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.